Patient Guide: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 33 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04774718
Status: 🟢 Enrolling Now
Condition: ALK Fusion-positive Solid or CNS Tumors
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 33 locations across the country.

Top locations include:
  • • Palo Alto, California
  • • St. Petersburg, Florida
  • • Ann Arbor, Michigan
  • • And 30 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors - Join Clinical Trial NCTNCT04774718

How to Join This Clinical Trial - NCTNCT04774718

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for ALK Fusion-positive Solid or CNS Tumors. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with ALK Fusion-positive Solid or CNS Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
ALK Fusion-positive Solid or CNS Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04774718 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 33 locations. Find a study site near you:

Clinical Research Site

Palo Alto, California 94304 - United States

Status: RECRUITING

Clinical Research Site

St. Petersburg, Florida 33701 - United States

Status: RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55404 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10065 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: RECRUITING

Clinical Research Site

Memphis, Tennessee 38105 - United States

Status: RECRUITING

Clinical Research Site

Randwick, New South Wales 2031 - Australia

Status: RECRUITING

Clinical Research Site

Parkville, Victoria 3052 - Australia

Status: RECRUITING

Clinical Research Site

Barretos, São Paulo 14784-400 - Brazil

Status: RECRUITING

And 23 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for ALK Fusion-positive Solid or CNS Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships